CVE-2016-1371

CVE-2016-1371 is a medium-severity vulnerability in Clamav with a CVSS 3.x base score of 5.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.

Key facts

Description

ClamAV (aka Clam AntiVirus) before 0.99.2 allows remote attackers to cause a denial of service (application crash) via a crafted mew packer executable.

Frequently asked questions

What is CVE-2016-1371?
ClamAV (aka Clam AntiVirus) before 0.99.2 allows remote attackers to cause a denial of service (application crash) via a crafted mew packer executable.
How severe is CVE-2016-1371?
CVE-2016-1371 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity none, and availability high.
Is CVE-2016-1371 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (74th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2016-1371?
CVE-2016-1371 primarily affects Clamav. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2016-1371?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2016-1371 published?
CVE-2016-1371 was published on 2016-10-03 and last updated on 2026-06-17.

References

Affected products (4)

More vulnerabilities in Clamav

All CVEs affecting Clamav →

Other CWE-284 (Improper Access Control) vulnerabilities

Browse all CWE-284 (Improper Access Control) vulnerabilities →